Navigation Links
Massachusetts Institute of Technology IDs new cancer drug target
Date:11/8/2010

CAMBRIDGE, Mass. -- Suppressing cancer cells' ability to replicate damaged DNA could dramatically enhance the effectiveness of chemotherapy drugs such as cisplatin, according to a new pair of papers from MIT biologists.

In studies of mice, the researchers found that slowing down a specific system for tolerating DNA damage not only prolonged survival but also prevented relapsed tumors from becoming resistant to chemotherapy, and made tumors much less likely to spread to other parts of the body.

Two enzymes that play key roles in a cell's response to DNA damage could be an enticing target for new cancer drugs, according to Michael Hemann and Graham Walker, senior authors of the two papers. Their new findings will appear in the Proceedings of the National Academy of Sciences during the week of Nov. 8.

Many cancer drugs, including cisplatin, kill cancer cells by damaging their DNA. This damage can impair a cell's ability to copy its DNA before cell division, resulting in cell death. However, cancer cells use enzymes known as translesion DNA polymerases to copy over damaged DNA and prevent the newly replicated DNA from having gaps in its normal sequence of nucleotide bases (the "rungs" of the ladder that forms the DNA double helix).

In these studies, the MIT researchers focused on two proteins, known as Rev3 and Rev1, which are subunits of translesion DNA polymerases.

In one of the PNAS papers, Hemann and Walker studied mice with a particularly aggressive form of lung cancer. Among mice treated with cisplatin, mice whose Rev3 levels were reduced by 60 to 70 percent lived twice as long as mice with the normal amount of Rev3. (Mice with reduced Rev3 lived an average of 22.5 days following cisplatin treatment; mice treated with cisplatin alone lived 11 days.) This is the first alteration shown to sensitize these tumors to front-line chemotherapy.

Translesion polymerases can be highly error-prone and thus i
'/>"/>

Contact: Jennifer Hirsch
jfhirsch@mit.edu
617-253-1682
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Massachusetts Hospital Agrees to Pay U.S. $2.79 Million to Resolve False Claims Act Allegations
2. Diabetics Twice as Likely to Have Hearing Loss; Massachusetts HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March
3. Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts
4. Miles for Hope’s Moving Towards A Cure(SM) Brain Tumor Walk in Boston Raising Funds for Brain Tumor Vaccine and Massachusetts General Hospital
5. Massachusetts health care reform reviewed as a model for national plan
6. Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge
7. Blue Cross Blue Shield of Massachusetts Demonstrates Community Commitment with Fifth William C. Van Faasen Community Service Sabbatical
8. Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract
9. Doctors hard to find for patients in Massachusetts first for-profit health plan
10. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
11. Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... By Steven Reinberg ... -- Women who are obese during pregnancy may be more ... new review suggests. "We found that, compared with children ... overweight or obese during pregnancy had up to 20 to ... Erick Forno, an assistant professor of pediatrics at Children,s Hospital ...
(Date:7/22/2014)... the University of Utah,s John A. Moran Eye Center, ... Research (ISER) as the recipient of the Houston, Texas-based ... Retina Research., The award recognizes lifetime achievement by a ... the understanding of vitreoretinal diseases or disorders. The award ... Meeting in San Francisco, where Marc will deliver a ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap Manchester ... MD. There has never been a better time in the ... success of the American national soccer team at the 2014 World ... that fans of the world’s sport will be able to feed ... Champions Cup. The tournament will kick off on July 24 and ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- One of the ... a psychiatric disorder has uncovered 83 new sites on ... The findings, made by an international team of researchers, ... linked to the disorder to 108. Although ... as a test to predict who will or will ...
Breaking Medicine News(10 mins):Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... GPRC5A gene, which is under-expressed in human lung cancer cells, ... key to attacking lung cancer in humans, researchers at The ... the Nov. 21 edition of The Journal of the National ... of their GPRC5A genes suppressed developed normally until their second ...
... current laws are too cumbersome , , TUESDAY, Nov. 13 ... in their efforts to protect human research subjects, a ... doctors recently surveyed said that the Health Insurance Portability ... patients, medical information, has hindered research. Only one-quarter felt ...
... Sorting Out the Bitters , Maik Behrens, ... , The story goes that bitter taste receptors ... course, have diverse chemical structures. It has been debated ... whether we need multiple bitter receptors. Bitter taste is ...
... delivery ... technology., CLEVELAND, ... patented, 81 milligram aspirin tablet that,dissolves rapidly in the mouth instead ... of Americans who maintain a,daily aspirin routine and worry about gastrointestinal ...
... Heartburn Alliance Sponsors First Ever Heartburn Awareness Month, ... ... remains a burning problem,for more than 60 million Americans each month(1), ... for heartburn,education by sponsoring the first ever Heartburn Awareness Month. ...
... ... Tennis Champions, CHATHAM, N.J., Nov. 13 The Justin ... Jersey. The event will take place on two dates. On Sunday,December 9, ... tournaments with professional tennis champions. On Thursday,December 13, at 7 PM fans ...
Cached Medicine News:Health News:M. D. Anderson researchers identify tumor-suppressor gene for lung cancer 2Health News:Rules on Patients' Medical Data Hampering Research 2Health News:Rules on Patients' Medical Data Hampering Research 3Health News:News Tips from the Journal of Neuroscience 2Health News:News Tips from the Journal of Neuroscience 3Health News:New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 3Health News:The Justin Gimelstob Children's Fund Hosts Tennis Exhibition 2
(Date:7/22/2014)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... quarter financial results on Tuesday, August 5, 2014, after ... host a live audio webcast immediately following the announcement ... business and financial update and discuss second quarter 2014 ... live audio webcast via the Investors & Media section ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 2014 Legislation backed by the drugstore ... Pharmacies Act of 2014") championing so-called "any willing ... the availability of lower cost preferred pharmacy networks ... the next 10 years, according to new research ... Care Management Association (PCMA). The drugstore ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... A unique collaborative effort among business leaders and health ... nation for health care has led to more than $12.8 ... days spent in the hospital and nearly 3,600 fewer adverse ... Solutions for Patient Safety initiative, launched in January 2009 ...
... Jan. 18, 2011 WebMD Health Corp. (Nasdaq: ... health information, has launched its Medscape from WebMD ... and tablets.  Medscape Mobile is the premier free ... professionals.  Since its release on the iPhone® and ...
Cached Medicine Technology:Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 2Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 3WebMD Launches Medscape for iPad™ and Android™ Devices 2WebMD Launches Medscape for iPad™ and Android™ Devices 3
... is an intracorporeal electrokinetic lithotripter particularly ... VIBROLITH guarantees satisfaction in application to ... gall bladder and salivary gland stones. ... percutaneous applications. Kinetic energy transmitted by ...
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
... Multiline offers an ideal combination of ... easy and effective treatment of urinary ... wide range of urological applications. ... images enabling rapid, precise stone localization. ...
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
Medicine Products: